SCHEMBL9707738

SCHEMBL9707738

COCCn1c(=O)c2c(nc(C3CCCCC3)n2Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(CCc2ccccc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
ADORA3 P0DMS8 3/20 0.41
NPSR1 Q6W5P4 3/20 0.40
MAPK1 P28482 2/20 0.40
POLB P06746 1/20 0.40
BLM P54132 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
PDE5A O76074 1/20 0.38
ADORA2B P29275 4/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
AGTR1 P30556 1/20 0.38
AGTR2 P50052 1/20 0.38
DCTPP1 Q9H773 1/20 0.38
THRB P10828 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707831 1.00 KMT2A (0.43) KMT2AADORA3NPSR1MAPK1POLB
SCHEMBL9708544 0.96 KMT2A (0.42) KMT2AADORA3NPSR1MAPK1POLB
SCHEMBL9708675 0.94 KMT2A (0.45) KMT2AADORA3NPSR1MAPK1POLB
SCHEMBL9708126 0.93 PDE5A (0.42) KMT2AADORA3NPSR1MAPK1POLB
SCHEMBL9708356 0.93 ADORA3 (0.45) KMT2AADORA3NPSR1MAPK1POLB
SCHEMBL9708002 0.92 ADORA3 (0.49) KMT2AADORA3PDE5AADORA2B
SCHEMBL9708332 0.92 PDE5A (0.46) KMT2AADORA3PDE5AADORA2BAGTR1
SCHEMBL9708029 0.92 ADORA3 (0.49) KMT2AADORA3PDE5AADORA2B
SCHEMBL9708482 0.92 PDE5A (0.43) KMT2AADORA3NPSR1MAPK1POLB
SCHEMBL9707983 0.92 PDE5A (0.42) KMT2AADORA3NPSR1MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed